Shedir Pharma Group Logo

Shedir Pharma Group

Researches, develops, and commercializes health and wellness products.

SHE | XMIL

Overview

Corporate Details

ISIN(s):
IT0005379620
LEI:
81560092B300849E9017
Country:
Italy
Address:
VIA BAGNULO, 95, 80063 PIANO DI SORRENTO

Description

Shedir Pharma Group specializes in the research, development, formulation, and commercialization of health and wellness products. The company's portfolio encompasses nutraceuticals, dermocosmetics, medical devices, and pharmaceuticals. A key focus is on innovation, resulting in the creation of unique and patented product formulations that cover approximately 15 therapeutic areas. The group operates through specialized subsidiaries that manage the entire product lifecycle, from initial research and intellectual property to marketing and distribution. Products are offered in various forms, such as capsules, tablets, powders, liquids, and gels, targeting professionals in the medical and pharmaceutical sectors.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-06-12 18:16
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
Italian 492.2 KB
2023-06-05 18:22
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
Italian 491.7 KB
2023-05-29 17:43
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
Italian 492.5 KB
2023-05-22 17:40
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
Italian 493.9 KB
2023-05-15 19:47
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
Italian 496.9 KB
2023-05-02 18:26
GGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
Italian 494.9 KB
2023-04-28 15:40
Assemblea ordinaria degli Azionisti del 28 aprile 2023
Italian 555.6 KB
2023-04-26 17:49
Shedir Pharma Group S.p.A. - Rettifica della tempistica relativa alle date di s…
Italian 771.5 KB
2023-04-24 16:27
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
Italian 674.1 KB
2023-04-20 13:07
RETTIFICA AVVISO CONVOCAZIONE ASSEMBLEA ORDINARIA DEGLI AZIONISTI
Italian 181.5 KB
2023-04-18 15:00
RICAVI PRIMO TRIMESTRE 2023 A + 44%
Italian 499.6 KB
2023-04-17 19:19
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
Italian 668.2 KB
2023-04-13 19:22
Deposito della Relazione Finanziaria Annuale 2022 e della documentazione assemb…
Italian 768.7 KB
2023-04-13 19:17
Pubblicazione avviso di convocazione Assemblea ordinaria degli Azionisti
Italian 647.8 KB
2023-04-11 18:07
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
Italian 669.3 KB

Automate Your Workflow. Get a real-time feed of all Shedir Pharma Group filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Shedir Pharma Group

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Shedir Pharma Group via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.